Industry

TORONTO–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, announced today that it has established an at-the-market equity program (the “ATM Program”) that allows Cybin to issue and sell up to USD$35,000,000 of common shares … [Read more…]

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) (“the Company”) announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is … [Read more…]

Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S.  NEW YORK & SAINT-HERBLAIN, France–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that it will contribute up to $400,000 in funding, colleague matching and in-kind donations to support organizations providing relief services to eastern Kentucky communities struck by historic flooding. HCA Healthcare will contribute to the following organizations: $100,000 to the … [Read more…]

Prospective Study Earlier Presented at the Annual Meeting of the American Academy of Ophthalmology (AAO) and Selected for Panel Discussion as an Outstanding work. First prospective clinical study on AI and color retinal image-based early diagnosis of AMD in outpatient settings and first such submission to FDA. Study design reviewed with FDA at a pre-submission … [Read more…]

Achieved sequential improvement in profitability and free cash flow ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, Matt Monaghan, chairman, president, and chief executive officer, said “In 2Q22, we achieved sequential revenue growth of 4.7% in mobility … [Read more…]

OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #boardofdirectors–Rockley Photonics (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Richard Kuntz, M.D., M.Sc., to its board of directors. Dr. Kuntz will join the board as an independent director, effective August 8, 2022. “We are delighted to welcome Richard Kuntz … [Read more…]

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, today announced the appointment of Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer, effective today, August 8, 2022. With over 20 years of experience in drug development … [Read more…]

Second Quarter Results Show Significant Sequential Improvement in Profitability Reduced Cash Usage by More than $30 Million Compared to First Quarter 2022 Strong Growth Compared to 2019 Pre-COVID Baseline: Total Digital and Nutritional Subscriptions +26%, Average Digital Retention +40BPS, Total Streams +22%, DAU/MAU +140BPS Secured $50 Million in Debt Financing EL SEGUNDO, Calif.–(BUSINESS WIRE)–The Beachbody … [Read more…]

SANTA BARBARA, Calif.–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2022. Second Quarter Highlights and Outlook Strong momentum with second quarter worldwide sales of $41.2 million, … [Read more…]